Blincyto® (blinatumomab)

For further information, please see the Injectable drugs page.

Code(s): J9039

Benefit: Medical

Notes: Per 1 mcg; treatment of Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL)